Dexela Limited Awarded Technology Strategy Board Grant For Work On Digital Breast Tomosynthesis
Dec 6th 2007Drug InformationBreast Cancer
Dexela, a leading company in Digital Breast Tomosynthesis, announced that it has been awarded a £360,000 grant by the Technology Strategy Board as part of a £1,600,000 collaborative research and development programme with two leading research universities. Support for the Project of £400,000 is also to be provided by the Engineering and Physical Sciences Research Council (EPSRC). [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
